Heparin - Troikaa Pharmaceuticals
Alternative Names: Heparin QPS - Troikaa; Heparin sodium - Troikaa; Heparin sodium topical solution 1000 IU/ml - Triokaa; Phlebotroy QPSLatest Information Update: 07 Jan 2022
At a glance
- Originator Troikaa Pharmaceuticals
- Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Thrombosis
Most Recent Events
- 25 Jun 2018 Troikaa Pharmaceuticals plans a phase II/III trial for Phlebitis in India (CTRI/2018/05/013701)
- 02 May 2017 Troikaa Pharmaceuticals initiates a phase III trial for Thrombosis (Prevention) in India (CTRI2017-03-008263)
- 30 Mar 2017 Launched for Thrombosis (Prevention) in India prior to March 2017 (Topical)